Transgene operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Transgene with three other
pharmaceutical manufacturers in Europe:
Erytech Pharma SA
sales of 4.14 million Euro [US$4.47 million]
(6.94 million Euro [US$7.49 million]
based in the United Kingdom
(£2.65 million [US$3.31 million]
of which 54%
During the year ended December of 2016, sales at
Transgene were 10.31 million Euro (US$11.13 million).
increase of 7.8%
versus 2015, when the company's sales were 9.57 million Euro.
Despite this increase, sales are still
below the level achieved in 2014, when Transgene
reported sales of 11.75 million Euro.